Event / Webinar

Bayesian Expert Prior Elicitation to Aid Decision Making in Biopharmaceutical Development

Expert knowledge is a valuable source of information to augment available data or when interpretation/synthesis of data requires expert judgement. Prior elicitation is a key tool for translating this expert knowledge and judgement into a quantitative probability distribution that can then be used in the design, analysis, and interpretation of clinical and observational studies.

On-Demand 1 hour Your Desk!

REGISTER NOW

**For more information, please see Cencora PharmaLex Privacy Policy. If you do not wish to receive any communication from us, you may unsubscribe at any time.

Speakers

Nicky Best

VP and Head of Statistics and Data Science Innovation, GSK

Brad Carlin

Senior Advisor, Data Science, PharmaLex

In this talk, we review the different approaches to elicit information from experts and summarize it in a probabilistic language, Bayesian prior distributions. We then focus on how expert knowledge from multiple experts can be summarized. Software to achieve such summaries is also discussed. The concepts and approaches are illustrated using a variety of real-life examples relating to different aspects of pharmaceutical product development. The talk shows Bayesian prior elicitation to be a feasible and useful aid to internal company decision making across the pharmaceutical product lifecycle chain.

Key learning objectives:

  • Maecenas feugiat felis erat.Understanding of prior distributions, their role in Bayesian inference, and the value they can bring to decision making across a drug’s life cycle
  • Review of the key elements of various elicitation approaches, including expert training and dossier preparation
  • Overview of the SHELF protocol and other related elicitation protocols (e.g., Delphi) and software packages
  • Understanding of how the methods can pay dividends in real-world examples
Download The free eBook